Norman B. Richter


BA, cum laude, Dartmouth College
JD, cum laude, University of Pennsylvania Law School


Norm Richter was the chief tax executive for Baxalta Inc, a biopharmaceutical multinational company focused on hematology, immunology and oncology, until Baxalta was acquired in June 2016 by Shire for $32 billion.  A year earlier, in July 2015, Baxalta Inc had been launched as a spin-off from Baxter International, a healthcare company based near Chicago which retained the medical devices business, and where Norm also served as the chief tax executive.  Prior to joining Baxter, Norm served as the chief tax executive of Textron Inc, a multi-industry global industrial company based in Rhode Island.  Before joining Textron, Norm worked in all three branches of the Federal government in various tax roles.  In Washington, D.C., he led the international tax counsel group in the Office of Tax Policy at the U.S. Treasury Department, served as majority tax counsel for the U.S. Senate Committee on Finance, and clerked for Judge Arthur Nims III of the U.S. Tax Court.   Norm also served as adjunct professor at Georgetown Law School’s LLM program.  Before joining the staff of the Senate Finance Committee, Norm was a tax attorney with the Steptoe & Johnson law firm in Washington, D.C. for four years. 

View all profiles